| Jumlah Saham Beredar | 15,492,681 shares |
| Saham Orang Dalam | 5,054,144 shares |
| Kepemilikan oleh Orang Dalam | 32.62 % |
| Orang Dalam Sejati | 27 |
Skor Sentimen Orang Dalam
Skor Sentimen Orang Dalam mengidentifikasi perusahaan yang dibeli oleh orang dalam korporat.
Ini adalah hasil dari model kuantitatif multifaktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi internal tertinggi. Model penilaian ini menggunakan kombinasi dari jumlah bersih orang dalam yang membeli dalam 90 hari sebelumnya, total saham yang dibeli sebagai persentase dari jumlah saham yang beredar, dan total saham yang dimiliki oleh orang dalam. Angka tersebut berkisar dari 0 hingga 100, dengan angka yang lebih tinggi menunjukkan tingkat akumulasi yang lebih tinggi dibandingkan dengan perusahaan sejenis, dan 50 adalah rata-rata.
Frekuensi Pembaruan: Setiap Hari
Skor Sentimen Petugas
Skor Sentimen Pejabat menemukan perusahaan yang dibeli oleh Pejabat Korporat.
Menurut definisi, Pejabat Korporasi adalah Orang Dalam Korporasi, tetapi tidak seperti beberapa Orang Dalam lainnya (Pemegang Saham 10% dan Anggota Dewan), Pejabat bekerja untuk perusahaan setiap hari, dan mereka menggunakan uang mereka sendiri saat bertransaksi . (Pemegang Saham 10% dan Anggota Dewan seringkali adalah manajer dana yang mengelola uang orang lain.) Dengan demikian, transaksi orang dalam yang dilakukan oleh Pejabat jauh lebih signifikan dan harus ditangani dengan tepat.
Seperti Skor Sentimen Internal, Skor Sentimen Pejabat adalah hasil dari model kuantitatif multi-faktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi pejabat tertinggi.
Frekuensi Pembaruan: Setiap Hari
Metrik Utama Orang Dalam
Kartu ini menunjukkan peringkat perusahaan berdasarkan berbagai metrik internal. Peringkat persentil menunjukkan bagaimana perusahaan ini dibandingkan dengan perusahaan lain di pasar AS. Peringkat yang lebih tinggi menunjukkan situasi yang lebih baik.
Sebagai contoh, secara umum diterima bahwa pembelian oleh orang dalam perusahaan adalah indikator positif, sehingga perusahaan dengan lebih banyak pembelian oleh orang dalam akan mendapat peringkat lebih tinggi daripada perusahaan dengan lebih sedikit pembelian oleh orang dalam (atau bahkan penjualan oleh orang dalam).
Jumlah Bersih Pembelian oleh Orang Dalam (Peringkat)
0 ( )
4442 out of 11323Jumlah Bersih Pembelian oleh Orang Dalam adalah total jumlah orang dalam yang membeli dikurangi total jumlah orang dalam yang menjual dalam 90 hari terakhir. Peringkat persentil ditunjukkan di sini (kisaran dari 0 hingga 100%).
Persentase Saham yang Dibeli oleh Orang Dalam (Peringkat)
0.000 %( )
4425 out of 11244Persentase Saham yang Dibeli oleh Orang Dalam adalah total jumlah saham yang dibeli oleh orang dalam dikurangi total jumlah saham yang dijual oleh orang dalam dalam 90 hari terakhir, dibagi dengan total jumlah saham yang beredar dan dikalikan dengan 100.
Grafik Perdagangan Orang Dalam
Grafik berikut menunjukkan CASI Pharmaceuticals, Inc. transaksi orang dalam. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Secara umum, melakukan transaksi di perusahaan mereka berdasarkan informasi material yang belum dipublikasikan adalah ilegal bagi orang dalam. Ini tidak berarti bahwa mereka dilarang melakukan transaksi apa pun di perusahaan mereka sendiri. Namun, mereka wajib melaporkan semua transaksi kepada SEC melalui Formulir 4.
Daftar Orang Dalam dan Metrik Profitabilitas
Tabel ini menampilkan daftar orang dalam yang diketahui, dan dibuat secara otomatis dari pengajuan yang diungkapkan kepada SEC. Selain nama, jabatan terbaru, dan sebutan direktur, pejabat, atau pemilik 10%, kami memberikan kepemilikan terbaru yang diungkapkan. Selain itu, jika memungkinkan, kami memberikan kinerja perdagangan historis untuk orang dalam tersebut. Kinerja perdagangan historis adalah rata-rata tertimbang dari kinerja transaksi pembelian pasar terbuka aktual yang dilakukan oleh orang dalam tersebut. Untuk informasi lebih lanjut tentang bagaimana ini dihitung, tonton webinar YouTube ini.
See our leaderboard of most profitable insider traders.
| Orang Dalam | Rata-rata Keuntungan (%) | Saham Dimiliki |
Terbagi Disesuaikan |
|---|---|---|---|
| Donald S Brooks | 25,000 | ||
| Dwight L Bush | 37,500 | ||
| Sara B Capitelli VP Fin & Principal Account Off - [O] | 0 | 0 | |
| George Chi | 0 | ||
| Cevera Jennie Hunter | 37,500 | ||
|
Wei-Wu He
Chairman and CEO, Director, 10% Owner -
[D]
[O]
|
644,553 | 644,553 | |
| Hu Cynthia W. COO, Gen Counsel & Secretary - [O] | 29,685 | 2,968 | |
| James Huang Director - [D] | 371,517 | 371,517 | |
|
IDG-Accel China Growth Fund III L.P.
10% Owner -
|
646,995 | 64,700 |
| Orang Dalam | Rata-rata Keuntungan (%) | Saham Dimiliki |
Terbagi Disesuaikan |
|---|---|---|---|
|
Dapeng Li
10% Owner -
|
11,312,325 | 1,131,232 | |
| Mak Tak W. Director - [D] | 365,376 | 365,376 | |
| Mark C M Randall | 50,000 | ||
| Ken Ren CEO and Director, Director - [D] [O] | 15,000 | 1,500 | |
| Ken Keyong Ren CEO and Director, Director - [D] [O] | 15,000 | 1,500 | |
| Rajesh C Md Shrotriya | 345,806 | ||
|
Byte Ltd Sparkle
10% Owner -
|
10,198,518 | 1,019,852 | |
|
Spectrum Pharmaceuticals Inc
10% Owner -
|
5,397,413 | 539,741 | |
| Franklin Cary jr Salisbury | 388,387 |
| Orang Dalam | Rata-rata Keuntungan (%) | Saham Dimiliki |
Terbagi Disesuaikan |
|---|---|---|---|
|
Hugo Shong
10% Owner -
|
10,198,518 | 1,019,852 | |
| Michael M Tarnow | 50,000 | ||
|
Strategy Holding Ltd Wealth
10% Owner -
|
9,087,888 | 908,789 | |
| Alex Wu | 35,000 | ||
| Yue Alexander Wu | 388,387 | ||
| Weihao Xu Chief Financial Officer - [O] | 4,000 | 400 | |
| Larry Zhang President - [O] | 20,153 | 2,015 | |
|
Quan Zhou
10% Owner -
|
380,645 | 64,700 | |
| Alexander A Zukiwski | 500,000 |
Report errors via our new Insider Auditing Tool
Rekam Jejak Pembelian Orang Dalam - Analisis Keuntungan Jangka Pendek
Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di CASI / CASI Pharmaceuticals, Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoretis .
Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).
Rekam Jejak Penjualan Orang Dalam - Analisis Kerugian Jangka Pendek
Dalam bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan dalam pasar terbuka yang tidak direncanakan oleh orang dalam yang dilakukan di CASI / CASI Pharmaceuticals, Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoretis .
Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
| Tanggal Perdagangan | Orang Dalam | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari-hari menuju Menit |
Harga di Menit |
Kerugian Maksimal Dihindari ($) |
Kerugian Maksimal Dihindari (%) |
|---|---|---|---|---|---|---|---|
| Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk orang dalam ini. |
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).
Riwayat Transaksi
Klik ikon tautan untuk melihat riwayat transaksi lengkap. Transaksi yang dilaporkan sebagai bagian dari rencana perdagangan otomatis 10b5-1 akan memiliki tanda X di kolom yang bertanda 10b-5.
| Berkas Tanggal |
Perdagangan Tanggal |
Formulir | Orang Dalam | Ticker | Judul Keamanan | Kode | Langsung | Latihan Harga |
Satuan Harga |
Unit Diubah |
Nilai Diubah (1 ribu) |
Sisa Pilihan |
Sisa Saham |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-09-08 | 2022-09-08 | 4 | Huang James | CASI | Common Stock | I | 4.2831 | 33,300 | 143 | 371,517 | ||||
| 2022-09-08 | 2022-09-07 | 4 | Huang James | CASI | Common Stock | I | 3.9965 | 3,111 | 12 | 338,217 | ||||
| 2022-09-08 | 2022-09-06 | 4 | Huang James | CASI | Common Stock | I | 3.8932 | 19,162 | 75 | 335,106 | ||||
| 2022-09-02 | 2022-09-02 | 4 | Huang James | CASI | Common Stock | I | 3.7413 | 400 | 1 | 315,944 | ||||
| 2022-09-02 | 2022-09-01 | 4 | Huang James | CASI | Common Stock | I | 3.7229 | 11,821 | 44 | 315,544 | ||||
| 2022-09-02 | 2022-08-31 | 4 | Huang James | CASI | Common Stock | I | 3.7450 | 24,975 | 94 | 303,723 | ||||
| 2022-08-26 | 2022-08-26 | 4 | Huang James | CASI | Common Stock | I | 3.7488 | 39,527 | 148 | 278,748 | ||||
| 2022-08-26 | 2022-08-24 | 4 | Huang James | CASI | Common Stock | I | 3.7502 | 5,000 | 19 | 239,221 | ||||
| 2022-08-23 | 2022-08-23 | 4 | Huang James | CASI | Common Stock | I | 3.4998 | 40,000 | 140 | 234,221 | ||||
| 2022-08-23 | 2022-08-22 | 4 | Huang James | CASI | Common Stock | I | 3.4641 | 23,105 | 80 | 194,221 | ||||
| 2022-08-23 | 2022-08-19 | 4 | Huang James | CASI | Common Stock | I | 3.2694 | 171,116 | 559 | 171,116 | ||||
| 2022-06-17 | 2022-06-15 | 4 | He Wei-Wu | CASI | Common Stock | D | 3.1800 | 50,000 | 159 | 644,553 | ||||
| 2022-06-17 | 2022-06-14 | 4 | He Wei-Wu | CASI | Common Stock | D | 3.0600 | 2,096 | 6 | 594,553 | ||||
| 2022-06-17 | 2022-06-13 | 4 | He Wei-Wu | CASI | Common Stock | D | 2.9700 | 36,058 | 107 | 592,457 | ||||
| 2022-05-26 | 2022-05-25 | 4 | Zhou Quan | CASI | Stock Option (Right to Buy) | D | 0.47 | 380,645 | 380,645 | |||||
| 2022-05-26 | 2022-05-25 | 4 | Salisbury Franklin Cary jr | CASI | Stock Option (Right to Buy) | D | 0.47 | 388,387 | 388,387 | |||||
| 2022-05-26 | 2022-05-25 | 4 | Huang James | CASI | Stock Option (Right to Buy) | D | 0.47 | 397,419 | 397,419 | |||||
| 2022-05-26 | 2022-05-25 | 4 | Wu Yue Alexander | CASI | Stock Option (Right to Buy) | D | 0.47 | 388,387 | 388,387 | |||||
| 2022-05-26 | 2022-05-25 | 4 | SHROTRIYA RAJESH C MD | CASI | Stock Option (Right to Buy) | D | 0.47 | 345,806 | 345,806 | |||||
| 2021-12-06 | 2021-12-02 | 4 | Zukiwski Alexander A | CASI | Employee Stock Option (Right to Buy) | D | 0.87 | -500,000 | 500,000 | |||||
| 2021-11-19 | 2021-11-18 | 4 | He Wei-Wu | CASI | Common Stock | D | 0.9800 | 200,000 | 196 | 5,558,472 | ||||
| 2021-11-19 | 2021-11-17 | 4 | He Wei-Wu | CASI | Common Stock | D | 0.9900 | 200,000 | 198 | 5,362,569 | ||||
| 2021-08-20 | 2021-08-19 | 4 | He Wei-Wu | CASI | Common Stock | D | 1.2600 | 180,000 | 227 | 5,163,994 | ||||
| 2021-08-20 | 2021-08-18 | 4 | He Wei-Wu | CASI | Common Stock | D | 1.2900 | 300,000 | 387 | 4,983,994 | ||||
| 2021-07-26 | 2021-07-24 | 4 | Zhang Larry | CASI | Employee Stock Option (Right to Buy) | D | 1.28 | -800,000 | 800,000 | |||||
| 2021-06-16 | 2021-06-15 | 4 | SHROTRIYA RAJESH C MD | CASI | Stock Option (Right to Buy) | D | 1.65 | 98 | 98,349 | |||||
| 2021-06-16 | 2021-06-15 | 4 | Zhou Quan | CASI | Stock Option (Right to Buy) | D | 1.65 | 108,257 | 108,257 | |||||
| 2021-06-16 | 2021-06-15 | 4 | Wu Yue Alexander | CASI | Stock Option (Right to Buy) | D | 1.65 | 110,459 | 110,459 | |||||
| 2021-06-16 | 2021-06-15 | 4 | He Wei-Wu | CASI | Stock Options (Right to Buy) | D | 1.73 | 4,000,000 | 4,000,000 | |||||
| 2021-06-16 | 2021-06-15 | 4 | Huang James | CASI | Stock Option (Right to Buy) | D | 1.65 | 113,028 | 113,028 | |||||
| 2021-06-16 | 2021-06-15 | 4 | Salisbury Franklin Cary jr | CASI | Stock Option (Right to Buy) | D | 1.65 | 110,459 | 110,459 | |||||
| 2021-03-30 | 2021-03-26 | 4 | He Wei-Wu | CASI | Common Stock | I | 2.0500 | 3,000,000 | 6,150 | 3,000,000 | ||||
| 2020-12-23 | 2020-12-22 | 4 | He Wei-Wu | CASI | Common Stock | D | -380,000 | 4,683,994 | ||||||
| 2020-12-18 | 3 | Xu Weihao Held by spouse | CASI | Common Stock | I | 4,000 | ||||||||
| 2020-12-18 | 2020-12-17 | 4 | Xu Weihao Held by spouse | CASI | Common Stock | I | 2.6300 | 2,279 | 6 | 10,000 | ||||
| 2020-12-18 | 2020-12-17 | 4 | Xu Weihao Held by spouse | CASI | Common Stock | I | 2.6400 | 1,721 | 5 | 7,721 | ||||
| 2020-12-18 | 2020-12-16 | 4 | Xu Weihao | CASI | Employee Stock Option (Right to Buy) | D | 2.61 | 800,000 | 800,000 | |||||
| 2020-12-18 | 2020-12-16 | 4 | Xu Weihao Held by spouse | CASI | Common Stock | I | 2.4400 | 2,000 | 5 | 6,000 | ||||
| 2020-11-24 | 2020-11-23 | 4 | He Wei-Wu | CASI | Common Stock | D | 2.1800 | 100,000 | 218 | 5,063,994 | ||||
| 2020-11-24 | 2020-11-20 | 4 | He Wei-Wu | CASI | Common Stock | D | 2.1200 | 127,471 | 270 | 4,963,994 | ||||
| 2020-07-24 | 2020-07-22 | 4 | Zhang Larry | CASI | Common Stock | D | 1.9000 | 20,153 | 38 | 20,153 | ||||
| 2020-07-24 | 2020-07-22 | 4 | He Wei-Wu | CASI | Common Stock | I | 1.9000 | 1,200,000 | 2,280 | 7,532,347 | ||||
| 2020-07-24 | 2020-07-22 | 4 | He Wei-Wu | CASI | Common Stock | D | 1.9000 | 2,952,426 | 5,610 | 4,836,523 | ||||
| 2020-06-18 | 2020-06-16 | 4 | Huang James | CASI | Stock Option (Right to Buy) | D | 2.63 | 70,400 | 70,400 | |||||
| 2020-06-18 | 2020-06-16 | 4 | Zhou Quan | CASI | Stock Option (Right to Buy) | D | 2.63 | 67,429 | 67,429 | |||||
| 2020-06-18 | 2020-06-16 | 4 | SHROTRIYA RAJESH C MD | CASI | Stock Option (Right to Buy) | D | 2.63 | 61,257 | 61,257 | |||||
| 2020-06-18 | 2020-06-16 | 4 | Salisbury Franklin Cary jr | CASI | Stock Option (Right to Buy) | D | 2.63 | 68,800 | 68,800 | |||||
| 2020-06-18 | 2020-06-16 | 4 | Wu Yue Alexander | CASI | Stock Option (Right to Buy) | D | 2.63 | 68,800 | 68,800 | |||||
| 2020-05-21 | 2020-05-20 | 4 | He Wei-Wu | CASI | Common Stock | D | 2.3700 | 56,464 | 134 | 1,884,097 | ||||
| 2020-05-21 | 2020-05-19 | 4 | He Wei-Wu | CASI | Common Stock | D | 2.0300 | 29,801 | 60 | 1,827,663 | ||||
| 2020-05-19 | 2020-05-18 | 4 | He Wei-Wu | CASI | Common Stock | D | 2.0200 | 338,932 | 685 | 1,797,832 | ||||
| 2020-05-19 | 2020-05-15 | 4 | He Wei-Wu | CASI | Common Stock | D | 1.8200 | 100,000 | 182 | 1,458,900 | ||||
| 2020-03-30 | 2020-03-27 | 4 | He Wei-Wu | CASI | Common Stock | D | 2.0800 | 6,880 | 14 | 1,358,900 | ||||
| 2020-03-27 | 2020-03-26 | 4 | He Wei-Wu | CASI | Common Stock | D | 2.0900 | 328,095 | 686 | 1,352,020 | ||||
| 2020-03-27 | 2020-03-25 | 4 | He Wei-Wu | CASI | Common Stock | D | 1.9400 | 196,398 | 381 | 1,023,925 | ||||
| 2020-03-19 | 2020-03-19 | 4 | He Wei-Wu | CASI | Common Stock | I | 1.5700 | 234,488 | 368 | 6,332,347 | ||||
| 2020-03-19 | 2020-03-18 | 4 | He Wei-Wu | CASI | Common Stock | I | 1.5200 | 501,322 | 762 | 6,097,859 | ||||
| 2020-03-19 | 2020-03-17 | 4 | He Wei-Wu | CASI | Common Stock | I | 1.5000 | 264,192 | 396 | 5,596,537 | ||||
| 2020-01-06 | 2019-12-30 | 4 | Wealth Strategy Holding Ltd | CASI | Warrant | D | 1.69 | 0.1250 | -493,827 | -62 | 0 | |||
| 2020-01-06 | 2019-12-30 | 4 | Wealth Strategy Holding Ltd | CASI | Common Stock | D | 1.6900 | 493,827 | 835 | 9,087,888 | ||||
| 2019-12-18 | 2019-12-16 | 4 | He Wei-Wu | CASI | Warrant | I | 1.69 | -374,321 | 0 | |||||
| 2019-12-18 | 2019-12-16 | 4 | He Wei-Wu | CASI | Common Stock | I | 1.6900 | 374,321 | 633 | 5,332,345 | ||||
| 2019-12-17 | 2019-12-15 | 4 | Zukiwski Alexander A | CASI | Employee Stock Option (Right to Buy) | D | 3.16 | -200,000 | 200,000 | |||||
| 2019-09-24 | 2019-09-20 | 4 | Zhang Larry | CASI | Employee Stock Option (Right to Buy) | D | 3.35 | -200,000 | 200,000 | |||||
| 2019-08-20 | 2019-08-16 | 4 | He Wei-Wu | CASI | Common Stock | D | 3.2000 | 20,000 | 64 | 827,527 | ||||
| 2019-08-15 | 2019-08-14 | 4 | He Wei-Wu | CASI | Common Stock | D | 3.1700 | 160,000 | 507 | 807,527 | ||||
| 2019-06-21 | 2019-06-20 | 4 | Zhou Quan | CASI | Stock Option (Right to Buy) | D | 3.13 | 56,731 | 56,731 | |||||
| 2019-06-21 | 2019-06-20 | 4 | He Wei-Wu | CASI | Stock Option (Right to Buy) | D | 2.85 | 4,000,000 | 4,000,000 | |||||
| 2019-06-21 | 2019-06-20 | 4 | SHROTRIYA RAJESH C MD | CASI | Stock Option (Right to Buy) | D | 3.13 | 51,538 | 51,538 | |||||
| 2019-06-21 | 2019-06-20 | 4 | Ren Ken Keyong | CASI | Stock Option (Right to Buy) | D | 3.13 | 51,538 | 51,538 | |||||
| 2019-06-21 | 2019-06-20 | 4 | Huang James | CASI | Stock Option (Right to Buy) | D | 3.13 | 59,231 | 59,231 | |||||
| 2019-06-21 | 2019-06-20 | 4 | Salisbury Franklin Cary jr | CASI | Stock Option (Right to Buy) | D | 3.13 | 57,885 | 57,885 | |||||
| 2019-06-21 | 2019-06-20 | 4 | Wu Yue Alexander | CASI | Stock Option (Right to Buy) | D | 3.13 | 57,885 | 57,885 | |||||
| 2019-04-04 | 2019-04-02 | 4 | SPECTRUM PHARMACEUTICALS INC | CASI | Common Stock | D | 3.3828 | -1,500,000 | -5,074 | 5,397,413 | ||||
| 2019-02-06 | 3 | Li Dapeng | CASI | Common Stock | D | 15,513,602 | ||||||||
| 2019-02-06 | 3 | Li Dapeng | CASI | Common Stock | D | 15,513,602 | ||||||||
| 2019-02-06 | 3 | Li Dapeng | CASI | Common Stock | D | 15,513,602 | ||||||||
| 2019-02-06 | 3 | Li Dapeng By Zhejiang Kanglaite Group Co., Ltd. | CASI | Common Stock | I | 11,312,325 | ||||||||
| 2019-02-06 | 3 | Li Dapeng | CASI | Common Stock | D | 10,278,975 | ||||||||
| 2019-02-06 | 3 | Li Dapeng By Zhejiang Kanglaite Group Co., Ltd. | CASI | Common Stock | I | 11,312,325 | ||||||||
| 2019-02-06 | 3 | Li Dapeng | CASI | Common Stock | D | 10,278,975 | ||||||||
| 2019-02-06 | 3 | Li Dapeng By Zhejiang Kanglaite Group Co., Ltd. | CASI | Common Stock | I | 11,312,325 | ||||||||
| 2019-02-06 | 3 | Li Dapeng | CASI | Common Stock | D | 10,278,975 | ||||||||
| 2019-01-31 | 2019-01-29 | 4 | Ren Ken Keyong | CASI | Stock Options (Right to Buy) | D | 0.88 | 75,000 | 75,000 | |||||
| 2019-01-31 | 2019-01-29 | 4 | Hu Cynthia W. | CASI | Stock Options (Right to Buy) | D | 0.88 | 75,000 | 75,000 | |||||
| 2019-01-15 | 2019-01-14 | 4 | Hu Cynthia W. | CASI | Employee Stock Option (Right to Buy) | D | 1.76 | -15,000 | 0 | |||||
| 2019-01-15 | 2019-01-14 | 4 | Hu Cynthia W. | CASI | Common Stock | D | 3.7900 | -3,100 | -12 | 29,685 | ||||
| 2019-01-15 | 2019-01-14 | 4 | Hu Cynthia W. | CASI | Common Stock | D | 1.7600 | 15,000 | 26 | 32,785 | ||||
| 2018-12-21 | 2018-12-19 | 4 | He Wei-Wu | CASI | Common Stock | D | -200,000 | 647,527 | ||||||
| 2018-12-06 | 2018-12-03 | 4 | Ren Ken Keyong | CASI | Stock Options (Right to Buy) | D | 0.99 | 720,000 | 720,000 | |||||
| 2018-11-14 | 2018-11-13 | 4 | SPARKLE BYTE LTD | CASI | Warrant | D | 1.69 | 0.1250 | -750,771 | -94 | 0 | |||
| 2018-11-14 | 2018-11-13 | 4 | SPARKLE BYTE LTD | CASI | Warrant | D | 1.69 | 0.1250 | -948,982 | -119 | 0 | |||
| 2018-11-14 | 2018-11-13 | 4 | SPARKLE BYTE LTD | CASI | Common Stock | D | 1.6900 | 1,699,753 | 2,873 | 10,198,518 | ||||
| 2018-10-31 | 3 | Wealth Strategy Holding Ltd | CASI | Common Stock | D | 17,188,122 | ||||||||
| 2018-10-31 | 3 | Wealth Strategy Holding Ltd | CASI | Common Stock | D | 17,188,122 | ||||||||
| 2018-10-31 | 3 | Wealth Strategy Holding Ltd | CASI | Common Stock | D | 17,188,122 | ||||||||
| 2018-10-02 | 2018-09-28 | 4 | Chi George | CASI | Stock Options (Right to Buy) | D | 4.67 | 400,000 | 400,000 | |||||
| 2018-07-13 | 2018-07-12 | 4 | CAPITELLI SARA B | CASI | Employee Stock Option (Right to Buy) | D | 1.98 | -35,000 | 0 | |||||
| 2018-07-13 | 2018-07-12 | 4 | CAPITELLI SARA B | CASI | Common Stock | D | 7.4893 | -26,600 | -199 | 0 | ||||
| 2018-07-13 | 2018-07-12 | 4 | CAPITELLI SARA B | CASI | Common Stock | D | 7.4893 | -8,400 | -63 | 26,600 | ||||
| 2018-07-13 | 2018-07-12 | 4 | CAPITELLI SARA B | CASI | Common Stock | D | 1.9850 | 35,000 | 69 | 35,000 | ||||
| 2018-07-03 | 2018-06-29 | 4 | SHROTRIYA RAJESH C MD | CASI | Stock Options (Right to Buy) | D | 8.23 | 35,000 | 35,000 | |||||
| 2018-07-03 | 2018-06-29 | 4 | Wu Alex | CASI | Stock Options (Right to Buy) | D | 8.23 | 35,000 | 35,000 | |||||
| 2018-07-03 | 2018-06-29 | 4 | Salisbury Franklin Cary jr | CASI | Stock Options (Right to Buy) | D | 8.23 | 35,000 | 35,000 | |||||
| 2018-07-03 | 2018-06-29 | 4 | Zhou Quan | CASI | Stock Options (Right to Buy) | D | 8.23 | 50,000 | 50,000 | |||||
| 2018-07-03 | 2018-06-29 | 4 | Huang James | CASI | Stock Options (Right to Buy) | D | 8.23 | 50,000 | 50,000 | |||||
| 2018-06-12 | 2018-06-11 | 4 | He Wei-Wu | CASI | Stock Options (Right to Buy) | D | 3.22 | 1,000,000 | 1,000,000 | |||||
| 2018-04-13 | 2018-04-12 | 4 | CAPITELLI SARA B | CASI | Employee Stock Option (Right to Buy) | D | 0.88 | -26,978 | 0 | |||||
| 2018-04-13 | 2018-04-12 | 4 | CAPITELLI SARA B | CASI | Common Stock | D | 6.6200 | -18,778 | -124 | 0 | ||||
| 2018-04-13 | 2018-04-12 | 4 | CAPITELLI SARA B | CASI | Common Stock | D | 6.6200 | -8,200 | -54 | 18,778 | ||||
| 2018-04-13 | 2018-04-12 | 4 | CAPITELLI SARA B | CASI | Common Stock | D | 0.8800 | 26,978 | 24 | 26,978 | ||||
| 2018-04-06 | 2018-04-04 | 4 | Huang James | CASI | Common Stock | D | 191 | 191 | ||||||
| 2018-04-06 | 2018-04-04 | 4 | Huang James | CASI | Common Stock | I | -416,666 | 0 | ||||||
| 2018-03-23 | 2018-03-21 | 4 | IDG-Accel China Growth Fund III L.P. | CASI | Warrant | D | 3.69 | 0.1250 | 1,152,839 | 144 | 81,728 | |||
| 2018-03-23 | 2018-03-21 | 4 | IDG-Accel China Growth Fund III L.P. See Explanation of Responses | CASI | Warrant | I | 3.69 | 0.1250 | 1,152,839 | 144 | 81,728 | |||
| 2018-03-23 | 2018-03-21 | 4 | IDG-Accel China Growth Fund III L.P. See Explanation of Responses | CASI | Common Stock | I | 3.1900 | 204,320 | 652 | 646,995 | ||||
| 2018-03-23 | 2018-03-21 | 4 | IDG-Accel China Growth Fund III L.P. | CASI | Common Stock | D | 3.1900 | 2,882,098 | 9,194 | 9,126,375 | ||||
| 2018-03-21 | 2018-03-19 | 4 | He Wei-Wu | CASI | Warrants (Right to Buy) | I | 3.69 | 1,234,567 | 1,234,567 | |||||
| 2018-03-21 | 2018-03-19 | 4 | He Wei-Wu | CASI | Common Stock | I | 3.2400 | 3,086,419 | 10,000 | 4,958,024 | ||||
| 2017-12-22 | 2017-12-22 | 4 | SPECTRUM PHARMACEUTICALS INC | CASI | Common Stock | I | 0.0100 | 611,740 | 6 | 4,650,262 | ||||
| 2017-12-22 | 2017-12-22 | 4 | SPECTRUM PHARMACEUTICALS INC | CASI | Common Stock | D | 0.0100 | 907,356 | 9 | 6,897,413 | ||||
| 2017-10-11 | 2017-10-10 | 4 | He Wei-Wu | CASI | Common Stock | D | 1.9500 | 100,000 | 195 | 847,527 | ||||
| 2017-10-10 | 2017-10-06 | 4 | He Wei-Wu | CASI | Common Stock | D | 1.8600 | 100,000 | 186 | 747,527 | ||||
| 2017-10-10 | 2017-10-05 | 4 | He Wei-Wu | CASI | Common Stock | D | 1.8000 | 100,000 | 180 | 647,527 | ||||
| 2017-10-06 | 2017-07-10 | 4 | Hu Cynthia W. | CASI | Stock Options (Right to Buy) | D | 1.01 | 50,000 | 50,000 | |||||
| 2017-10-03 | 2017-09-29 | 4 | Hu Cynthia W. | CASI | Stock Options (Right to Buy) | D | 1.98 | 50,000 | 50,000 | |||||
| 2017-10-03 | 2017-09-29 | 4 | CAPITELLI SARA B | CASI | Stock Options (Right to Buy) | D | 1.98 | 20,000 | 20,000 | |||||
| 2017-09-20 | 2017-09-19 | 4 | He Wei-Wu | CASI | Common Stock | D | 1.7800 | 34,002 | 61 | 547,527 | ||||
| 2017-09-20 | 2017-09-18 | 4 | He Wei-Wu | CASI | Common Stock | D | 1.7500 | 173,500 | 304 | 513,525 | ||||
| 2017-09-18 | 2017-09-15 | 4 | He Wei-Wu | CASI | Common Stock | D | 1.4900 | 127,702 | 190 | 340,025 | ||||
| 2017-09-18 | 2017-09-14 | 4 | He Wei-Wu | CASI | Common Stock | D | 1.2200 | 187,625 | 229 | 212,323 | ||||
| 2017-06-09 | 2017-06-08 | 4 | Hu Cynthia W. | CASI | Stock Options (Right to Buy) | D | 1.01 | 100,000 | 100,000 | |||||
| 2017-06-09 | 2017-06-08 | 4 | Zhou Quan | CASI | Stock Options (Right to Buy) | D | 1.01 | 50,000 | 50,000 | |||||
| 2017-06-09 | 2017-06-08 | 4 | He Wei-Wu | CASI | Stock Options (Right to Buy) | D | 1.01 | 100,000 | 100,000 | |||||
| 2017-06-09 | 2017-06-08 | 4 | Huang James | CASI | Stock Options (Right to Buy) | D | 1.01 | 50,000 | 50,000 | |||||
| 2017-06-09 | 2017-06-08 | 4 | Salisbury Franklin Cary jr | CASI | Stock Options (Right to Buy) | D | 1.01 | 35,000 | 35,000 | |||||
| 2017-06-09 | 2017-06-08 | 4 | SHROTRIYA RAJESH C MD | CASI | Stock Options (Right to Buy) | D | 1.01 | 35,000 | 35,000 | |||||
| 2017-06-09 | 2017-06-08 | 4 | Wu Alex | CASI | Stock Options (Right to Buy) | D | 1.01 | 35,000 | 35,000 | |||||
| 2017-06-09 | 2017-06-08 | 4 | CAPITELLI SARA B | CASI | Stock Options (Right to Buy) | D | 1.01 | 50,000 | 50,000 | |||||
| 2017-04-05 | 2017-04-03 | 4 | Zukiwski Alexander A | CASI | Stock Options (Right to Buy) | D | 1.34 | 300,000 | 300,000 | |||||
| 2016-11-01 | 2016-10-28 | 4 | SPECTRUM PHARMACEUTICALS INC | CASI | Common Stock | I | 0.0100 | 198,765 | 2 | 4,038,522 | ||||
| 2016-11-01 | 2016-10-28 | 4 | SPECTRUM PHARMACEUTICALS INC | CASI | Common Stock | I | 0.0100 | 521,692 | 5 | 3,839,757 | ||||
| 2016-11-01 | 2016-10-28 | 4 | SPECTRUM PHARMACEUTICALS INC | CASI | Common Stock | D | 0.0100 | 294,815 | 3 | 5,990,057 | ||||
| 2016-11-01 | 2016-10-28 | 4 | SPECTRUM PHARMACEUTICALS INC | CASI | Common Stock | D | 0.0100 | 773,790 | 8 | 5,695,242 | ||||
| 2016-10-25 | 2016-10-24 | 4 | He Wei-Wu | CASI | Stock Options (Right to Buy) | D | 1.40 | 202,247 | 202,247 | |||||
| 2016-10-05 | 2016-10-03 | 4 | Ren Ken Keyong | CASI | Stock Options (Right to Buy) | D | 1.11 | 308,571 | 308,571 | |||||
| 2016-10-05 | 2016-10-03 | 4 | He Wei-Wu See footnotes | CASI | Warrants | I | 1.69 | 0.0250 | 374,321 | 9 | 374,321 | |||
| 2016-10-05 | 2016-10-03 | 4 | He Wei-Wu | CASI | Stock Options (Right to Buy) | D | 1.11 | 366,343 | 366,343 | |||||
| 2016-10-05 | 2016-10-03 | 4 | He Wei-Wu See footnotes | CASI | Common Stock | I | 1.1900 | 1,871,605 | 2,227 | 1,871,605 | ||||
| 2016-08-16 | 2016-07-20 | 4 | SPECTRUM PHARMACEUTICALS INC | CASI | Common Stock | I | 0.0100 | 66,255 | 1 | 3,318,065 | ||||
| 2016-08-16 | 2016-07-20 | 4 | SPECTRUM PHARMACEUTICALS INC | CASI | Common Stock | D | 0.0100 | 98,271 | 1 | 4,921,452 | ||||
| 2016-08-16 | 2016-07-14 | 4 | SPECTRUM PHARMACEUTICALS INC | CASI | Common Stock | I | 0.0100 | 394,942 | 4 | 3,251,810 | ||||
| 2016-08-16 | 2016-07-14 | 4 | SPECTRUM PHARMACEUTICALS INC | CASI | Common Stock | D | 0.0100 | 585,790 | 6 | 4,823,181 | ||||
| 2016-07-06 | 2016-07-05 | 4 | He Wei-Wu | CASI | Stock Options (Right to Buy) | D | 1.10 | 84,507 | 84,507 | |||||
| 2016-06-29 | 2016-06-24 | 4 | SPARKLE BYTE LTD | CASI | Warrant | D | 1.69 | 0.0250 | 750,771 | 19 | 1,699,753 | |||
| 2016-06-29 | 2016-06-24 | 4 | SPARKLE BYTE LTD | CASI | Common Stock | D | 1.1900 | 3,753,855 | 4,467 | 8,498,765 | ||||
| 2016-06-27 | 2016-06-24 | 4 | He Wei-Wu | CASI | Stock Options (Right to Buy) | D | 1.15 | 369,805 | 369,805 | |||||
| 2016-06-27 | 2016-06-24 | 4 | Hu Cynthia W. | CASI | Stock Options (Right to Buy) | D | 1.15 | 27,027 | 27,027 | |||||
| 2016-06-27 | 2016-06-24 | 4 | Ren Ken Keyong | CASI | Stock Options(Right to Buy) | D | 1.15 | 86,486 | 86,486 | |||||
| 2016-06-03 | 2016-06-02 | 4 | He Wei-Wu | CASI | Stock Options (Right to Buy) | D | 0.86 | 712,112 | 712,112 | |||||
| 2016-06-03 | 2016-06-02 | 4 | Hu Cynthia W. | CASI | Stock Options (Right to Buy) | D | 0.86 | 87,719 | 87,719 | |||||
| 2016-06-03 | 2016-06-02 | 4 | Ren Ken Keyong | CASI | Stock Options (Right to Buy) | D | 0.86 | 280,701 | 280,701 | |||||
| 2016-06-03 | 2016-06-02 | 4 | Zhou Quan | CASI | Stock Options (Right to Buy) | D | 1.26 | 50,000 | 50,000 | |||||
| 2016-03-11 | 2016-02-22 | 4 | SPECTRUM PHARMACEUTICALS INC | CASI | Common Stock | I | 0.0100 | 680,113 | 7 | 2,856,868 | ||||
| 2016-03-11 | 2016-02-22 | 4 | SPECTRUM PHARMACEUTICALS INC | CASI | Common Stock | D | 0.0100 | 1,008,764 | 10 | 4,237,391 | ||||
| 2016-03-04 | 2016-03-02 | 4 | Hu Cynthia W. | CASI | Stock Options (Right to Buy) | D | 0.88 | 95,000 | 95,000 | |||||
| 2016-03-04 | 2016-03-02 | 4 | Mak Tak W. | CASI | Stock Options (Right to Buy) | D | 0.88 | 35,000 | 35,000 | |||||
| 2016-03-04 | 2016-03-02 | 4 | Huang James | CASI | Options (Right to Buy) | D | 0.88 | 75,000 | 75,000 | |||||
| 2016-03-04 | 2016-03-02 | 4 | CAPITELLI SARA B | CASI | Stock Options (Right to Buy) | D | 0.88 | 35,000 | 35,000 | |||||
| 2016-03-04 | 2016-03-02 | 4 | Ren Ken Keyong | CASI | Stock Options (Right to Buy) | D | 0.88 | 125,000 | 125,000 | |||||
| 2016-03-04 | 2016-03-02 | 4 | Salisbury Franklin Cary jr | CASI | Stock Options (Right to Buy) | D | 0.88 | 35,000 | 35,000 | |||||
| 2016-03-04 | 2016-03-02 | 4 | SHROTRIYA RAJESH C MD | CASI | Stock Options (Right to Buy) | D | 0.88 | 35,000 | 35,000 | |||||
| 2016-03-04 | 2016-03-02 | 4 | He Wei-Wu | CASI | Stock Options (Right to Buy) | D | 0.88 | 100,000 | 100,000 | |||||
| 2016-03-04 | 2016-03-02 | 4 | Wu Alex | CASI | Options (Right to Buy) | D | 0.88 | 35,000 | 35,000 | |||||
| 2016-01-27 | 3 | Zhou Quan See Explanation of Responses | CASI | Common Stock | I | 4,702,708 | ||||||||
| 2016-01-27 | 3 | Zhou Quan | CASI | Common Stock | D | 8,529,449 | ||||||||
| 2016-01-27 | 3 | Zhou Quan See Explanation of Responses | CASI | Common Stock | I | 4,702,708 | ||||||||
| 2016-01-27 | 3 | Zhou Quan | CASI | Common Stock | D | 8,529,449 | ||||||||
| 2016-01-27 | 3 | Zhou Quan See Explanation of Responses | CASI | Common Stock | I | 4,702,708 | ||||||||
| 2016-01-27 | 3 | Zhou Quan See Explanation of Responses | CASI | Common Stock | I | 4,702,708 | ||||||||
| 2016-01-27 | 3 | Zhou Quan See Explanation of Responses | CASI | Common Stock | I | 4,702,708 | ||||||||
| 2016-01-27 | 3 | Zhou Quan | CASI | Common Stock | D | 8,529,449 | ||||||||
| 2016-01-27 | 3 | Zhou Quan See Explanation of Responses | CASI | Common Stock | I | 4,702,708 | ||||||||
| 2016-01-27 | 3 | Zhou Quan | CASI | Common Stock | D | 8,529,449 | ||||||||
| 2016-01-27 | 3 | Zhou Quan | CASI | Common Stock | D | 8,529,449 | ||||||||
| 2016-01-27 | 3 | Zhou Quan | CASI | Common Stock | D | 8,529,449 | ||||||||
| 2016-01-27 | 3 | Zhou Quan See Explanation of Responses | CASI | Common Stock | I | 4,702,708 | ||||||||
| 2016-01-27 | 3 | Zhou Quan | CASI | Common Stock | D | 8,529,449 | ||||||||
| 2016-01-27 | 2013-03-07 | 4 | IDG-Accel China Growth Fund III L.P. See Explanation of Responses | CASI | Warrant | I | 2.91 | 34,479 | 92,044 | |||||
| 2016-01-27 | 2013-03-07 | 4 | IDG-Accel China Growth Fund III L.P. | CASI | Warrant | D | 2.91 | 486,354 | 1,298,354 | |||||
| 2016-01-27 | 2013-03-07 | 4 | IDG-Accel China Growth Fund III L.P. See Explanation of Responses | CASI | Common Stock | I | 2.4000 | 68,958 | 165 | 360,947 | ||||
| 2016-01-27 | 2013-03-07 | 4 | IDG-Accel China Growth Fund III L.P. | CASI | Common Stock | D | 2.4000 | 972,708 | 2,334 | 5,091,438 | ||||
| 2016-01-25 | 3 | Shong Hugo | CASI | Common Stock | D | 9,489,820 | ||||||||
| 2016-01-25 | 3 | Shong Hugo | CASI | Common Stock | D | 9,489,820 | ||||||||
| 2016-01-25 | 3 | Shong Hugo | CASI | Common Stock | D | 9,489,820 | ||||||||
| 2016-01-25 | 3 | Shong Hugo | CASI | Common Stock | D | 9,489,820 | ||||||||
| 2016-01-25 | 3 | Shong Hugo | CASI | Common Stock | D | 9,489,820 | ||||||||
| 2016-01-25 | 3 | Shong Hugo | CASI | Common Stock | D | 9,489,820 | ||||||||
| 2016-01-25 | 3 | Shong Hugo | CASI | Common Stock | D | 9,489,820 | ||||||||
| 2016-01-25 | 3 | Shong Hugo | CASI | Common Stock | D | 9,489,820 | ||||||||
| 2016-01-25 | 3 | Shong Hugo | CASI | Common Stock | D | 9,489,820 | ||||||||
| 2016-01-25 | 3 | Shong Hugo | CASI | Common Stock | D | 9,489,820 | ||||||||
| 2016-01-21 | 2016-01-19 | 4 | Ren Ken Keyong | CASI | Common Stock | D | 0.7100 | 300 | 0 | 15,000 | ||||
| 2016-01-21 | 2016-01-19 | 4 | Ren Ken Keyong | CASI | Common Stock | D | 0.7200 | 6,063 | 4 | 14,700 | ||||
| 2016-01-21 | 2016-01-19 | 4 | Ren Ken Keyong | CASI | Common Stock | D | 0.7400 | 1,100 | 1 | 8,637 | ||||
| 2016-01-21 | 2016-01-19 | 4 | Ren Ken Keyong | CASI | Common Stock | D | 0.7300 | 7,537 | 6 | 7,537 | ||||
| 2016-01-21 | 2016-01-19 | 4 | Ren Ken | CASI | Common Stock | D | 0.7100 | 300 | 0 | 15,000 | ||||
| 2016-01-21 | 2016-01-19 | 4 | Ren Ken | CASI | Common Stock | D | 0.7200 | 6,063 | 4 | 14,700 | ||||
| 2016-01-21 | 2016-01-19 | 4 | Ren Ken | CASI | Common Stock | D | 0.7400 | 1,100 | 1 | 8,637 | ||||
| 2016-01-21 | 2016-01-19 | 4 | Ren Ken | CASI | Common Stock | D | 0.7300 | 7,537 | 6 | 7,537 | ||||
| 2016-01-21 | 2016-01-19 | 4 | Hu Cynthia W. | CASI | Common Stock | D | 0.7197 | 11,837 | 9 | 17,785 | ||||
| 2016-01-21 | 2016-01-19 | 4 | Hu Cynthia W. | CASI | Common Stock | D | 0.7190 | 4,163 | 3 | 5,948 | ||||
| 2016-01-21 | 2016-01-19 | 4 | Hu Cynthia W. | CASI | Common Stock | D | 0.7497 | 400 | 0 | 1,785 | ||||
| 2016-01-21 | 2016-01-19 | 4 | Hu Cynthia W. | CASI | Common Stock | D | 0.7478 | 400 | 0 | 1,385 | ||||
| 2015-04-08 | 2015-04-06 | 4 | Hu Cynthia W. | CASI | Stock Options (Right to Buy) | D | 1.41 | 175,000 | 175,000 | |||||
| 2015-04-08 | 2015-04-06 | 4 | Mak Tak W. | CASI | Stock Options(Right to Buy) | D | 1.41 | 35,000 | 35,000 | |||||
| 2015-04-08 | 2015-04-06 | 4 | Huang James | CASI | Options(Right to Buy) | D | 1.41 | 75,000 | 75,000 | |||||
| 2015-04-08 | 2015-04-06 | 4 | Wu Alex | CASI | Options(Right to Buy) | D | 1.41 | 35,000 | 35,000 | |||||
| 2015-04-08 | 2015-04-06 | 4 | CAPITELLI SARA B | CASI | Stock Options (Right to Buy) | D | 1.41 | 65,000 | 65,000 | |||||
| 2015-04-08 | 2015-04-06 | 4 | He Wei-Wu | CASI | Stock Options (Right to Buy) | D | 1.41 | 100,000 | 100,000 | |||||
| 2015-04-08 | 2015-04-06 | 4 | Ren Ken Keyong | CASI | Stock Options(Right to Buy) | D | 1.41 | 225,000 | 225,000 | |||||
| 2015-04-08 | 2015-04-06 | 4 | Salisbury Franklin Cary jr | CASI | Stock Options(Right to Buy) | D | 1.41 | 35,000 | 35,000 | |||||
| 2015-04-08 | 2015-04-06 | 4 | SHROTRIYA RAJESH C MD | CASI | Stock Options(Right to Buy) | D | 1.41 | 35,000 | 35,000 | |||||
| 2014-11-14 | 2012-08-15 | 4 | CAPITELLI SARA B | CASI | Stock Options (Right to Buy) | D | 1.98 | 20,000 | 20,000 | |||||
| 2014-11-14 | 2014-04-03 | 4 | Hu Cynthia W. | CASI | Stock Options (Right to Buy) | D | 1.84 | 100,000 | 100,000 | |||||
| 2014-11-14 | 2012-08-15 | 4 | Hu Cynthia W. | CASI | Stock Options (Right to Buy) | D | 1.98 | 50,000 | 50,000 | |||||
| 2014-11-14 | 2014-04-03 | 4 | Huang James | CASI | Options(Right to Buy) | D | 1.84 | 100,000 | 100,000 | |||||
| 2014-11-14 | 2014-04-03 | 4 | He Wei-Wu | CASI | Stock Options (Right to Buy) | D | 1.84 | 100,000 | 100,000 | |||||
| 2014-11-14 | 2014-04-03 | 4 | Ren Ken Keyong | CASI | Stock Options(Right to Buy) | D | 1.84 | 100,000 | 100,000 | |||||
| 2014-09-25 | 3 | Spectrum Pharmaceuticals Cayman, L.P. | CASI | Common Stock | I | 7,582,137 | ||||||||
| 2014-09-25 | 3 | Spectrum Pharmaceuticals Cayman, L.P. | CASI | Common Stock | I | 7,582,137 | ||||||||
| 2014-09-25 | 3 | Spectrum Pharmaceuticals Cayman, L.P. | CASI | Common Stock | D | 8,634,009 | ||||||||
| 2014-09-25 | 3 | Spectrum Pharmaceuticals Cayman, L.P. | CASI | Common Stock | I | 7,582,137 | ||||||||
| 2014-09-25 | 3 | Spectrum Pharmaceuticals Cayman, L.P. | CASI | Common Stock | D | 8,634,009 | ||||||||
| 2014-09-25 | 3 | Spectrum Pharmaceuticals Cayman, L.P. | CASI | Common Stock | D | 8,634,009 | ||||||||
| 2014-09-23 | 2014-09-22 | 4 | SHROTRIYA RAJESH C MD | CASI | Stock Options (Right to Buy) | D | 1.80 | 50,000 | 50,000 | |||||
| 2014-06-03 | 2014-06-02 | 4 | Salisbury Franklin Cary jr | ENMD | Stock Options (Right to Buy) | D | 1.74 | 50,000 | 50,000 | |||||
| 2014-04-04 | 2014-04-03 | 4 | Hu Cynthia W. | ENMD | Stock Options (Right to Buy) | D | 1.84 | 130,000 | 130,000 | |||||
| 2014-04-04 | 2014-04-03 | 4 | He Wei-Wu | ENMD | Stock Options (Right to Buy) | D | 1.84 | 100,000 | 100,000 | |||||
| 2014-04-04 | 2014-04-03 | 4 | Ren Ken Keyong | ENMD | Stock Options(Right to Buy) | D | 1.84 | 150,000 | 150,000 | |||||
| 2014-04-04 | 2014-04-03 | 4 | CAPITELLI SARA B | ENMD | Stock Options (Right to Buy) | D | 1.84 | 55,000 | 55,000 | |||||
| 2014-04-04 | 2014-04-03 | 4 | Wu Alex | ENMD | Options (Right to Buy) | D | 1.84 | 25,000 | 25,000 | |||||
| 2014-04-04 | 2014-04-03 | 4 | Mak Tak W. | ENMD | Stock Options (Right to Buy) | D | 1.84 | 25,000 | 25,000 | |||||
| 2014-04-04 | 2014-04-03 | 4 | Huang James | ENMD | Options (Right to Buy) | D | 1.84 | 75,000 | 75,000 | |||||
| 2013-05-31 | 2013-05-30 | 4 | CAPITELLI SARA B | ENMD | Stock Options (Right to Buy) | D | 1.79 | 125,000 | 125,000 | |||||
| 2013-05-31 | 2013-05-30 | 4 | HUNTER CEVERA JENNIE | ENMD | Stock Options (Right to Buy) | D | 1.79 | 37,500 | 37,500 | |||||
| 2013-05-31 | 2013-05-30 | 4 | Hu Cynthia W. | ENMD | Stock Options (Right to Buy) | D | 1.79 | 350,000 | 350,000 | |||||
| 2013-05-31 | 2013-05-30 | 4 | He Wei-Wu | ENMD | Stock Options (Right to Buy) | D | 1.79 | 100,000 | 100,000 | |||||
| 2013-05-31 | 2013-05-30 | 4 | He Wei-Wu | ENMD | Stock Options (Right to Buy) | D | 1.79 | 125,000 | 125,000 | |||||
| 2013-05-31 | 2013-05-30 | 4 | Huang James | ENMD | Stock Options (Right to Buy) | D | 1.79 | 50,000 | 50,000 | |||||
| 2013-05-31 | 2013-05-30 | 4 | Wu Alex | ENMD | Stock Options (Right to Buy) | D | 1.79 | 50,000 | 50,000 | |||||
| 2013-05-31 | 2013-05-30 | 4 | BUSH DWIGHT L | ENMD | Stock Options (Right to Buy) | D | 1.79 | 37,500 | 37,500 | |||||
| 2013-05-31 | 2013-05-30 | 4 | Mak Tak W. | ENMD | Stock Options (Right to Buy) | D | 1.79 | 37,500 | 37,500 | |||||
| 2013-05-31 | 2013-05-30 | 4 | Ren Ken Keyong | ENMD | Stock Options (Right to Buy) | D | 1.79 | 1,000,000 | 1,000,000 | |||||
| 2013-04-12 | 3 | Huang James See footnotes | ENMD | Common Stock | I | 416,666 | ||||||||
| 2012-08-17 | 2012-08-15 | 4 | Hu Cynthia W. | ENMD | Stock Options (Right to Buy) | D | 1.98 | 75,000 | 75,000 | |||||
| 2012-08-17 | 2012-08-15 | 4 | CAPITELLI SARA B | ENMD | Stock Options (Right to Buy) | D | 1.98 | 35,000 | 35,000 | |||||
| 2012-05-03 | 2012-05-01 | 4 | He Wei-Wu | ENMD | Common Stock | I | 441,072 | 441,072 | ||||||
| 2012-05-03 | 2012-01-20 | 4 | He Wei-Wu | ENMD | Warrants (Right to Buy) | I | 1.40 | 86,957 | 86,957 | |||||
| 2012-05-03 | 2012-05-01 | 4 | Hu Cynthia W. | ENMD | Common Stock | I | 74,982 | 74,982 | ||||||
| 2012-05-03 | 2012-01-20 | 4 | Hu Cynthia W. | ENMD | Warrant (Right to Buy) | I | 1.40 | 14,783 | 14,783 | |||||
| 2012-05-03 | 2012-05-01 | 4 | Mak Tak W. | ENMD | Common Stock | D | 352,857 | 365,376 | ||||||
| 2012-05-03 | 2012-01-20 | 4 | Mak Tak W. | ENMD | Warrants (Right to Buy) | D | 1.40 | 69,565 | 69,565 | |||||
| 2012-04-03 | 2012-04-02 | 4 | Ren Ken Keyong | ENMD | Stock Options (Right to Buy) | D | 2.16 | 150,000 | 150,000 | |||||
| 2012-03-14 | 2012-03-12 | 4 | BUSH DWIGHT L | ENMD | Stock Options (Right to Buy) | D | 2.30 | 100,000 | 100,000 | |||||
| 2012-03-14 | 2012-03-12 | 4 | Mak Tak W. | ENMD | Stock Options (Right to Buy) | D | 2.30 | 125,000 | 125,000 | |||||
| 2012-03-14 | 2012-03-12 | 4 | HUNTER CEVERA JENNIE | ENMD | Stock Options (Right to Buy) | D | 2.30 | 50,000 | 50,000 | |||||
| 2012-03-14 | 2012-03-12 | 4 | RANDALL MARK C M | ENMD | Stock Options (Right to Buy) | D | 2.30 | 50,000 | 50,000 | |||||
| 2012-03-02 | 2012-03-01 | 4 | He Wei-Wu | ENMD | Stock Options (Right to Buy) | D | 1.95 | 250,000 | 250,000 | |||||
| 2012-02-13 | 3 | Mak Tak W. | ENMD | Common Stock | D | 12,519 | ||||||||
| 2012-02-13 | 3 | He Wei-Wu | ENMD | Common Stock | D | 24,698 | ||||||||
| 2012-01-25 | 2012-01-23 | 4 | Hu Cynthia W. | ENMD | Stock Options (Right to Buy) | D | 1.75 | 100,000 | 100,000 | |||||
| 2012-01-25 | 2012-01-23 | 4 | BROOKS DONALD S | ENMD | Stock Options (Right to Buy) | D | 1.75 | 25,000 | 25,000 | |||||
| 2012-01-25 | 2012-01-23 | 4 | TARNOW MICHAEL M | ENMD | Stock Options (Right to Buy) | D | 1.75 | 50,000 | 50,000 | |||||
| 2012-01-25 | 2012-01-23 | 4 | BUSH DWIGHT L | ENMD | Stock Options (Right to Buy) | D | 1.75 | 50,000 | 50,000 |
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)
